The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deleterious alterations in DNA-damage repair (daDDR) genes as a predictive biomarker for platinum-based chemotherapy in metastatic pancreatic ductal adenocarcinoma (mPDAC).
 
Sofia Palacio
No Relationships to Disclose
 
Hannah Stowe McMurry
No Relationships to Disclose
 
Robert Ali
No Relationships to Disclose
 
Talia Donenberg
No Relationships to Disclose
 
Rachel Silva-Smith
No Relationships to Disclose
 
Gina Wideroff
No Relationships to Disclose
 
Daniel A. Sussman
No Relationships to Disclose
 
Caio Max Sao Pedro Rocha Lima
Speakers' Bureau - Celgene
 
Peter Joel Hosein
Consulting or Advisory Role - AngioDynamics; Angiodynamics; Autem Medical; Celgene; Ipsen; Medtronic
Research Funding - AstraZeneca (Inst); Boston Biomedical (Inst); Kite, a Gilead company (Inst)